[Federal Register Volume 78, Number 51 (Friday, March 15, 2013)]
[Notices]
[Page 16514]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-06042]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Secretary's Advisory Committee on Heritable Disorders in Newborns
and Children; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463, codified at 5 U.S.C. App. 2), notice is
hereby given of the following meeting:
Name: Secretary's Advisory Committee on Heritable Disorders in
Newborns and Children (SACHDNC).
Date and Time: April 19, 2013, 9:30 a.m. to 3:00 p.m.
Place: Virtual via Webinar.
Status: The meeting is open to the public. Pre-registration is
required. For more information on registration and webinar details,
please visit the SACHDNC Web site: http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.
Purpose: The Secretary's Advisory Committee on Heritable
Disorders in Newborns and Children (SACHDNC), as authorized by
Public Law 106-310, which added section 1111 of the Public Health
Service Act, codified at 42 U.S.C. 300b-10, was established by
Congress to advise the Secretary of the Department of Health and
Human Services regarding the development of newborn screening
activities, technologies, policies, guidelines, and programs for
effectively reducing morbidity and mortality in newborns and
children having, or at risk for, heritable disorders. The SACHDNC's
recommendations regarding additional conditions/inherited disorders
for screening that have been adopted by the Secretary are included
in the Recommended Uniform Screening Panel (RUSP) that constitutes
part of the comprehensive guidelines supported by the Health
Resources and Services Administration. Pursuant to section 2713 of
the Public Health Service Act, codified at 42 U.S.C. 300gg-13, non-
grandfathered health plans are required to cover screenings included
in the comprehensive guidelines without charging a co-payment, co-
insurance, or deductible for plan years (i.e., policy years)
beginning on or after the date that is one year from the Secretary's
adoption of the condition for screening. The SACHDNC also provides
advice and recommendations concerning grants and projects authorized
under section 1109 of the Public Health Service Act (42 U.S.C. 300b-
8).
Agenda: The meeting will include: (1) A policy paper report on
the impact of recommendations related to sickle cell trait testing;
(2) a presentation on the Affordable Care Act and the impact on
individuals with heritable disorders; (3) a presentation by the
Agency for Healthcare Research and Quality regarding the processes
behind the U.S. Preventive Services Task Force review process; and
(4) project reports on screening for Tyrosinemia Type I and Point of
Care Screening and Lessons Learned.
Proposed agenda items are subject to change as priorities
dictate. The agenda, webinar information, Committee Roster, Charter,
presentations, and meeting materials are located on the Advisory
Committee's Web site at http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.
Public Comments: Members of the public can submit written
comments and/or register to present oral comments. All comments,
whether oral or written, are part of the official Committee record
and will be available for public inspection and copying. Individuals
who wish to make public comments are required to register for the
webinar and email Lisa Vasquez ([email protected]) by April 10,
2013. The public comment period is scheduled for the morning of
April 19, 2013. Written comments should be emailed to Lisa Vasquez
([email protected]) by April 10, 2013.
Written comments should identify the individual's name, address,
email, telephone number, professional or business affiliation, type
of expertise (i.e., parent, researcher, clinician, public health,
etc.) and the topic/subject matter of comment. To ensure that all
individuals who have registered to make oral comments can be
accommodated, the allocated time may be limited. Individuals who are
associated with groups or have similar interests may be requested to
combine their comments and present them through a single
representative. No audiovisual presentations are permitted.
Contact Person: Anyone interested in obtaining other relevant
information should contact the designated federal officer (DFO),
Debi Sarkar, Maternal and Child Health Bureau, Health Resources and
Services Administration, Room 18A-19, Parklawn Building, 5600
Fishers Lane, Rockville, Maryland 20857; telephone: 301-443-1080;
email: [email protected].
More information on the Advisory Committee is available at
http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.
Dated: March 11, 2013.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2013-06042 Filed 3-14-13; 8:45 am]
BILLING CODE 4165-15-P